• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Is Synchrony Financial (SYF) Cheap After Its CareCredit Vetspire Tie Up?

    Simply Wall St·10/09/2026 00:34:41
    Listen to the news

    Synchrony Financial (SYF) just pushed deeper into pet healthcare financing, with its CareCredit unit integrating directly into Vetspire’s AI clinic platform to offer embedded payment options at the point of veterinary care.

    Recent trading around Synchrony Financial has been choppy, with a 1-day share price return of 2.49% and a 7-day share price gain of 3.09% offset by a 30-day share price decline of 6.23% and a year-to-date share price fall of 12.91%. Over a longer horizon, the picture looks different. The 1-year total shareholder return is 5.58%, and the very large 3-year total shareholder return points to strong compounding. The Vetspire and recent marketing summit updates arrive against a backdrop of slower near term momentum and a US$73.72 share price that some investors may see as reflecting a change in sentiment or perceived risk around the story.

    Spot opportunities beyond Synchrony Financial by scanning a hand-picked 27 high quality undervalued stocks that combines solid cash flows with balance sheet strength.

    Synchrony Financial now pairs a strong credit franchise with a fresh push into pet healthcare financing. The real tension for investors is simple: Does a US$73.72 share price already capture that strength, or not?

    Most Popular Narrative: 18% Undervalued

    The most followed narrative pegs Synchrony Financial’s fair value at $89.43, above the recent $73.72 close. This frames the CareCredit and AI push as more valuable than the current quote implies.

    The company's proactive investment in advanced data analytics, AI, and end to end digital platforms has progressed through deployment of OpenAI models, the appointment of a Chief AI Officer, and AI enabled tools across underwriting, servicing, disputes, collections, and merchant onboarding, which can support net interest margins and earnings through both credit quality and operating efficiency.

    See why 34 investors see Synchrony Financial as 18% undervalued.

    Result: Fair Value of $89.43 (UNDERVALUED)

    Still, the story around Synchrony Financial can break if revenue and net interest margin shortfalls persist or if higher operating costs continue to pressure efficiency.

    Find out about the key risks to this Synchrony Financial narrative.

    Next Steps

    Views on Synchrony Financial appear mixed so far, with some investors leaning one way or the other. If you want to move quickly and base your own view on the numbers, consider both the potential upside and the red flags in the 4 key rewards and 2 important warning signs.

    Looking for more investment ideas beyond Synchrony Financial?

    If Synchrony Financial has sharpened your focus on quality, broaden your watchlist now with a few targeted stock ideas sourced directly from the Simply Wall St screener.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.